Raymond James reiterated coverage on Catalyst Biosciences with a new price target
$CBIO
Raymond James reiterated coverage of Catalyst Biosciences with a rating of Outperform and set a new price target of $19.00 from $18.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/15/2021 | Outperform → Market Perform | Raymond James | |
| 8/6/2021 | $19.00 → $18.00 | Outperform | Raymond James |